BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND TRA AND Treatment
8 results:

  • 1. Effect of tra-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model.
    Frederick PJ; Kendrick JE; Straughn JM; Della Manna DL; Oliver PG; Lin HY; Grizzle WE; Stockard CR; Alvarez RD; Zhou T; LoBuglio AF; Buchsbaum DJ
    Int J Gynecol Cancer; 2009 Jul; 19(5):814-9. PubMed ID: 19574765
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genetically modified cellular vaccines for therapy of human papilloma virus type 16 (HPV 16)-associated tumours.
    Bubenik J
    Curr Cancer Drug Targets; 2008 May; 8(3):180-6. PubMed ID: 18473731
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Anti-tumor activity of the tra-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.
    Kendrick JE; Straughn JM; Oliver PG; Wang W; Nan L; Grizzle WE; Stockard CR; Alvarez RD; Buchsbaum DJ
    Gynecol Oncol; 2008 Mar; 108(3):591-7. PubMed ID: 18177927
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Anti-tumor activity of tra-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.
    Straughn JM; Oliver PG; Zhou T; Wang W; Alvarez RD; Grizzle WE; Buchsbaum DJ
    Gynecol Oncol; 2006 Apr; 101(1):46-54. PubMed ID: 16271751
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials.
    Braud AC; Gonzague L; Bertucci F; Genre D; Camerlo J; Gravis G; Goncalves A; Moutardier V; Viret F; Maraninchi D; Viens P
    Eur Cytokine Netw; 2002; 13(1):115-20. PubMed ID: 11956030
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokinetics.
    Goncalves A; Camerlo J; Bun H; Gravis G; Genre D; Bertucci F; Resbeut M; Pech-Gourg F; Durand A; Maraninchi D; Viens P
    Anticancer Res; 2001; 21(2B):1431-7. PubMed ID: 11396227
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix: clinical and pharmacokinetic studies. New York Gynecologic Oncology Group.
    Wadler S; Schwartz EL; Haynes H; Rameau R; Quish A; Mandeli J; Gallagher R; Hallam S; Fields A; Goldberg G; McGill F; Jennings S; Wallach RC; Runowicz CD
    Cancer; 1997 Apr; 79(8):1574-80. PubMed ID: 9118041
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma.
    Liaudet-Coopman ED; Berchem GJ; Wellstein A
    Clin Cancer Res; 1997 Feb; 3(2):179-84. PubMed ID: 9815670
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.